Potential candidates include suppressor of cytokine signaling (SOCS), a negative regulator of cytokine signaling that is silenced by methylation in some tumors [17,18] and various receptor tyrosine kinases such as EGFR and c-met that are activated in cancers [19,20]. This evidence concerns the gene MET and cancer.